Serum β-hCG and neutrophil lymphocyte ratio in early second trimester of pregnancy and prediction of pre-eclampsia
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20254078Keywords:
Serum β-hCG, NLR, Preeclampsia, Biomarkers, Early predictionAbstract
Background: Hypertensive disorders, especially preeclampsia (PE), continues to challenge obstetric care, contributing substantially to maternal and perinatal morbidity and mortality. Reliable biomarkers for early prediction are needed. Biomarkers such as serum beta-human chorionic gonadotropin (β-hCG) and neutrophil-to-lymphocyte ratio (NLR) are emerging as potential tools for early risk stratification.
Methods: This prospective observational study included 86 pregnant women attending antenatal care at a tertiary care hospital. Serum β-hCG and NLR were measured between 13-20 weeks of gestation, and participants were followed until delivery. The development of PE was recorded, and associations with biochemical and clinical parameters were analysed using t tests, chi-square tests, and ROC curves.
Results: Of the 86 participants, 17.4% developed PE. Mean serum β-hCG was significantly higher in the PE group (60719 mIU/ml) vs. normotensive group (24952 mIU/ml, p=0.002)). MeanNLR was also elevated in PE (4.409) compared to normotensive women (3.010, p=0.002). A β-hCG cut-off of 57213 mIU/ml had a specificity of 93% for predicting PE. Higher BMI and multigravidity were significantly associated with PE (p=0.049 and p=0.029, respectively). PE was linked with earlier gestational age at delivery (35.13 vs. 37.56 weeks, p=0.013) and lower birth weight (2.53 kg vs. 2.93 kg, p=0.019).
Conclusions: Elevated second-trimester β-hCG and NLR, are significantly associated with an increased risk of PE. These accessible and cost-effective markers can aid in the early identification of high-risk pregnancies, allowing for timely interventions to improve maternal and foetal outcomes.
Metrics
References
Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237-60. DOI: https://doi.org/10.1097/AOG.0000000000003891
WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Available at: https://www.who.int/publications/i/item/9789241548335. Accessed on 19 November 2025.
Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta. 2009;30(A):S32-7. DOI: https://doi.org/10.1016/j.placenta.2008.11.009
Murmu S, Dwivedi J. Second-Trimester Maternal Serum Beta-Human Chorionic Gonadotropin and Lipid Profile as a Predictor of Gestational Hypertension, Preeclampsia, and Eclampsia: A Prospective Observational Study. Int J Appl Basic Med Res. 2020;10(1):49-53. DOI: https://doi.org/10.4103/ijabmr.IJABMR_271_19
Chowdhary H, Khurshid R, Parveen S, Yousuf S, Tali SH, Shah ZA. Utility of second trimester beta HCG levels in prediction of gestational hypertension: a prospective cohort study. Int J Reprod Contracept Obstet Gynecol. 2017;6(3):1040-4. DOI: https://doi.org/10.18203/2320-1770.ijrcog20170581
Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11(5):309-16. DOI: https://doi.org/10.1016/j.siny.2006.04.001
Panwar M, Kumari A, Hp A, Arora R, Singh V, Bansiwal R. Raised neutrophil lymphocyte ratio and serum beta hCG level in early second trimester of pregnancy as predictors for development and severity of preeclampsia. Drug Discov Ther. 2019;13(1):34-7. DOI: https://doi.org/10.5582/ddt.2019.01006
Yavuzcan A, Cağlar M, Ustün Y, Dilbaz S, Ozdemir I, Yildiz E, et al. Mean platelet volume, neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in severe preeclampsia. Ginekol Pol. 2014;85(3):197-203. DOI: https://doi.org/10.17772/gp/1713
Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565. DOI: https://doi.org/10.1136/bmj.38380.674340.E0
Lamminpää R, Vehviläinen-Julkunen K, Gissler M, Heinonen S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997-2008. BMC Pregnancy Childbirth. 2012;12(1):47. DOI: https://doi.org/10.1186/1471-2393-12-47
Redman CWG, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol N Y N 1989. 2010;63(6):534-43. DOI: https://doi.org/10.1111/j.1600-0897.2010.00831.x
Gupte S, Wagh G. Preeclampsia-eclampsia. J Obstet Gynaecol India. 2014;64(1):4-13. DOI: https://doi.org/10.1007/s13224-014-0502-y
Ehrenthal DB, Jurkovitz C, Hoffman M, Jiang X, Weintraub WS. Prepregnancy body mass index as an independent risk factor for pregnancy-induced hypertension. J Womens Health 2002. 2011;20(1):67-72. DOI: https://doi.org/10.1089/jwh.2010.1970
Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab TEM. 2007;18(10):365-70. DOI: https://doi.org/10.1016/j.tem.2007.09.003
Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol. 2002;155(3):203-9. DOI: https://doi.org/10.1093/aje/155.3.203
Guida JP de S, Dias TZ, Lajos GJ, Nomura ML, Pacagnella R de C, Tedesco RP, et al. Hypertensive disorders during pregnancy as a major cause of preterm birth and adverse perinatal outcomes: findings from a Brazilian National Survey. Einstein Sao Paulo Braz. 2024;22:eAO0514. DOI: https://doi.org/10.31744/einstein_journal/2024AO0514
Yilgwan CS, Pam VC, Yilgwan G, Ige OO, Golit WN, Anzaku S, et al. Comparing neonatal outcomes in women with preeclampsia and those with normal pregnancy. Niger J Paediatr. 2020;47(3):258-63. DOI: https://doi.org/10.4314/njp.v47i3.11
Gagnon A, Wilson RD, Society of obstetricians and gynaecologists of canada genetics committee. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can JOGC J Obstet Gynecol Can JOGC. 2008;30(10):918-32. DOI: https://doi.org/10.1016/S1701-2163(16)32973-5
Huma Z, Jabbar S, Arshad F, Kashif S, Ali R, Khawer N. Determine the Diagnostic Accuracy of High Beta HCG Levels in Predicting Pregnancy Induced Hypertension. Pak J Med Health Sci. 2022;16(06):98. DOI: https://doi.org/10.53350/pjmhs2216698
Downloads
Published
How to Cite
Issue
Section
